Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 199

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 7
Chunk 199
---
 to which we, or our subsidiaries, are party.

Cooperation Agreement with SciSparc
Ltd.

On March 7, 2022, we entered into a cooperation
agreement with SciSparc, pursuant to which we will explore with SciSparc the scientific and commercial potential for creating pharmaceutical
solutions for several indications including CNS related indications. Under such agreement, the companies are exploring a combined molecule
that the parties have created that is undergoing a joint pre-clinical study. To date, the collaboration has resulted in the filing of
nine patent applications. To the extent the parties determine to proceed to a commercial cooperation, they will enter into a joint venture
where the parties share the economics and rights on a 50%-50% basis. To date, no determination has been made to pursue the joint venture
and the development of the molecule remains in a very early stage.

Adi Zuloff-Shani, our Chief Executive Officer,
serves as SciSparc’s Chief Technologies Officer; Amitay Weiss, the Chairman of our Board of Directors, serves as the Chairman of
the Board of Directors of SciSparc; and Oz Adler, one of our directors, serves as the Chief Executive Officer and Chief Financial Officer
of SciSparc.

In June 2023, we announced that, as part of our
ongoing collaboration with SciSparc, we entered into a research agreement with the Hebrew University of Jerusalem to evaluate our and
SciSparc’s combination treatment for obesity and metabolic syndrome.

Agreements and Arrangements With,
and Compensation of, Directors and Executive Officers

We have entered into written employment agreements
or service agreements with each of our executive officers. All of these agreements contain customary provisions regarding noncompetition,
confidentiality of information and assignment of inventions. See “ Item 6. A. Directors and Senior Management - Compensation.”

Indemnification Agreements

Our articles of association provide that we may
indemnify any of our directors, former directors, officers or former officers, any other person and his or her heirs and legal personal
representatives against all eligible penalties to which such person is or may be liable, and we may, after the final disposition of an
eligible proceeding, pay the expenses actually and reasonably incurred by such person in respect of that proceeding. Each of our directors
and officers is deemed to have contracted with us on terms of the indemnity contained in our articles of association. In addition, we
may